Literature DB >> 17366029

Efficacy of serum procalcitonin in evaluating severity of community-acquired pneumonia in childhood.

Massimiliano Don1, Francesca Valent, Matti Korppi, Edmondo Falleti, Alessandro De Candia, Lolita Fasoli, Alfred Tenore, Mario Canciani.   

Abstract

Microbe-specific diagnosis of community-acquired pneumonia (CAP) in childhood is difficult in clinical practice. Chest radiographs and non-specific inflammatory markers have been used to separate presumably bacterial from viral infection but the results have been inconsistent. The aim of the present study was to evaluate the usefulness of procalcitonin (PCT) in assessing the severity as well as the bacterial or viral aetiology of CAP. Serum PCT was measured by an immunoluminometric assay in 100 patients with CAP; 26 were treated as inpatients and 74 as outpatients. The pulmonary infiltrate was considered to be alveolar in 62 and interstitial in 38 cases, according to the radiological diagnosis. The bacterial and viral aetiology of pneumonia was studied by an extensive serological test panel. No differences were found in PCT concentrations between the 4 aetiological (pneumococcal, atypical bacterial, viral, unknown) and the 3 age (< 2, 2-4 and > or = 5 y) groups. Serum PCT was >0.5 ng/ml in 69%, >1.0 ng/ml in 54% and >2.0 ng/ml in 47% of all patients. PCT was higher in patients that were admitted than as outpatients (medians 17.81 vs 0.72 ng/ml, respectively, p<0.01) and higher in alveolar than in interstitial pneumonia (medians 9.43 vs 0.53 ng/ml, respectively, p<0.01). In conclusion, serum PCT values were found to be related to the severity of CAP in children even though they were not capable, at any level of serum concentration, to differentiate between bacterial and viral aetiology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17366029     DOI: 10.1080/00365540600951283

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  21 in total

1.  Serum procalcitonin is not an early marker of pulmonary exacerbation in children with cystic fibrosis.

Authors:  Jacoba Johanna Louw; Jaan Toelen; Marijke Proesmans; François Vermeulen; Jaak Billen; Kris de Boeck
Journal:  Eur J Pediatr       Date:  2011-06-01       Impact factor: 3.183

2.  Biomarkers for Predicting Illness Severity in Children With Acute Lower Respiratory Tract Infections.

Authors:  Samir S Shah; Lilliam Ambroggio; Todd A Florin
Journal:  J Pediatric Infect Dis Soc       Date:  2014-05-14       Impact factor: 3.164

3.  Pediatric community-acquired pneumonia in the ambulatory setting.

Authors:  Massimiliano Don; Francesca Valent
Journal:  Eur J Pediatr       Date:  2009-12-09       Impact factor: 3.183

4.  The role of procalcitonin in respiratory infections.

Authors:  Laura Certain; Philipp Schuetz
Journal:  Curr Infect Dis Rep       Date:  2012-06       Impact factor: 3.725

5.  Responses to Bacteria, Virus, and Malaria Distinguish the Etiology of Pediatric Clinical Pneumonia.

Authors:  Clarissa Valim; Rushdy Ahmad; Miguel Lanaspa; Yan Tan; Sozinho Acácio; Michael A Gillette; Katherine D Almendinger; Danny A Milner; Lola Madrid; Karell Pellé; Jaroslaw Harezlak; Jacob Silterra; Pedro L Alonso; Steven A Carr; Jill P Mesirov; Dyann F Wirth; Roger C Wiegand; Quique Bassat
Journal:  Am J Respir Crit Care Med       Date:  2016-02-15       Impact factor: 21.405

6.  Biomarkers and Disease Severity in Children With Community-Acquired Pneumonia.

Authors:  Todd A Florin; Lilliam Ambroggio; Cole Brokamp; Yin Zhang; Mantosh Rattan; Eric Crotty; Michael A Belsky; Sara Krueger; Thomas N Epperson; Andrea Kachelmeyer; Richard Ruddy; Samir S Shah
Journal:  Pediatrics       Date:  2020-05-13       Impact factor: 7.124

Review 7.  A systematic review on the diagnosis of pediatric bacterial pneumonia: when gold is bronze.

Authors:  Tim Lynch; Liza Bialy; James D Kellner; Martin H Osmond; Terry P Klassen; Tamara Durec; Robin Leicht; David W Johnson
Journal:  PLoS One       Date:  2010-08-06       Impact factor: 3.240

8.  Prediction of delayed recovery from pediatric community-acquired pneumonia.

Authors:  Massimiliano Don; Francesca Valent; Mario Canciani; Matti Korppi
Journal:  Ital J Pediatr       Date:  2010-07-29       Impact factor: 2.638

9.  Hyponatremia in pediatric community-acquired pneumonia.

Authors:  Massimiliano Don; Giuliana Valerio; Matti Korppi; Mario Canciani
Journal:  Pediatr Nephrol       Date:  2008-07-08       Impact factor: 3.714

Review 10.  Clinical Progress Note: Procalcitonin in the Management of Pediatric Lower Respiratory Tract Infection.

Authors:  Sophie E Katz; Laura F Sartori; Derek J Williams
Journal:  J Hosp Med       Date:  2019-09-18       Impact factor: 2.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.